| LH/Mav |
systolic blood pressure |
control condition (between 147 and 154 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
84.0 days
| 12 |
between 9a-1p |
|
152.0 |
mmHg |
3.0 |
10.39 |
tail cuff plethysmography |
|
0.0 |
|
|
103432 |
2825 |
| LH/Mav |
urine total protein excretion rate |
control condition (between 147 and 154 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
total urine protein amount |
male |
147.0 days-154.0 days |
6 |
|
|
241.0 |
mg/d |
26.0 |
63.69 |
urine protein colorimetric analysis |
|
0.0 |
|
|
103448 |
2825 |
| LH/Mav |
systolic blood pressure |
control condition |
Dubay C, et al., Nat Genet 1993 Apr;3(4):354-7 |
arterial blood pressure trait |
male |
203.0 days-217.0 days |
16 |
|
serial mean |
174.1 |
mmHg |
|
|
vascular indwelling catheter method |
abdominal aorta |
10800 |
|
|
11645 |
111 |
| LH/Mav |
pulse pressure |
control condition |
Dubay C, et al., Nat Genet 1993 Apr;3(4):354-7 |
arterial blood pressure trait |
male |
203.0 days-217.0 days |
16 |
|
serial mean |
43.3 |
mmHg |
|
|
vascular indwelling catheter method |
abdominal aorta |
10800 |
|
|
11650 |
111 |
| LH/Mav |
systolic blood pressure |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
arterial blood pressure trait |
male |
112.0 days
| 8 |
undefined |
|
169.0 |
mmHg |
5.0 |
14.14 |
tail cuff plethysmography |
|
0.0 |
|
|
102808 |
2723 |
| LH/Mav |
body weight |
control condition (for 84 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
body mass |
male |
84.0 days
| 12 |
|
|
353.0 |
g |
8.0 |
27.71 |
body weighing method |
|
0.0 |
|
|
103424 |
2825 |
| LH/Mav |
urine protein excretion rate |
control condition (for 84 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
total urine protein amount |
male |
84.0 days
| 12 |
|
|
85.0 |
mg/d |
7.0 |
24.25 |
urine protein colorimetric analysis |
|
0.0 |
|
|
103444 |
2825 |
| LH/Mav |
systolic blood pressure |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
arterial blood pressure trait |
male |
84.0 days
| 5 |
|
|
161.0 |
mmHg |
6.0 |
13.42 |
tail cuff plethysmography |
|
0.0 |
|
|
103473 |
2826 |
| LH/Mav |
body weight |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
body mass |
male |
84.0 days
| 5 |
|
|
360.0 |
g |
6.0 |
13.42 |
body weighing method |
|
0.0 |
|
|
103479 |
2826 |
| LH/Mav |
urine total protein excretion rate to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
total urine protein amount |
male |
133.0 days
| 10 |
|
|
30.59 |
mg/d/100 g |
2.64 |
8.35 |
pyrogallol red-molybdate complex-based urine total protein analysis |
|
0.0 |
|
|
102041 |
2645 |
| LH/Mav |
urine total protein excretion rate |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
total urine protein amount |
male |
112.0 days
| 4 |
|
|
191.0 |
mg/d |
13.0 |
26.0 |
urine protein analysis |
|
0.0 |
|
|
102811 |
2723 |
| LH/Mav |
systolic blood pressure |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
arterial blood pressure trait |
male |
112.0 days
| 4 |
undefined |
|
157.0 |
mmHg |
7.0 |
14.0 |
tail cuff plethysmography |
|
0.0 |
|
|
102809 |
2723 |
| LH/Mav |
body weight |
control condition (between 147 and 154 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
body mass |
male |
147.0 days-154.0 days |
6 |
|
|
433.0 |
g |
7.0 |
17.15 |
body weighing method |
|
0.0 |
|
|
103428 |
2825 |
| LH/Mav |
urine sodium excretion rate to body weight ratio |
control condition (for 84 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
urine sodium amount |
male |
84.0 days
| 12 |
|
|
0.0 |
uEq/min/g |
0.0 |
0.0 |
flame photometry |
|
0.0 |
|
|
103460 |
2825 |
| LH/Mav |
heart left ventricle weight to body weight ratio |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
heart left ventricle mass |
male |
84.0 days
| 5 |
|
|
2.43 |
mg/g |
0.08 |
0.18 |
post excision weight measurement |
|
0.0 |
|
|
103485 |
2826 |
| LH/Mav |
body weight |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
body mass |
male |
161.0 days
| 4 |
|
|
431.0 |
g |
8.0 |
16.0 |
body weighing method |
|
0.0 |
|
|
102805 |
2723 |
| LH/Mav |
urine total protein excretion rate |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
total urine protein amount |
male |
161.0 days
| 4 |
|
|
370.0 |
mg/d |
32.0 |
64.0 |
urine protein analysis |
|
0.0 |
|
|
102813 |
2723 |
| LH/Mav |
diastolic blood pressure |
control condition (between 147 and 154 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
147.0 days-154.0 days |
6 |
2hr mean (10a-12p) |
continuous mean |
116.0 |
mmHg |
4.0 |
9.8 |
vascular fluid filled catheter |
|
0.0 |
|
|
103440 |
2825 |
| LH/Mav |
creatinine clearance to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
133.0 days
| 10 |
|
|
0.45 |
ml/min/100g |
0.01 |
0.03 |
automated blood creatinine analysis |
|
0.0 |
|
. |
102029 |
2645 |
| LH/Mav |
body weight |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
body mass |
male |
112.0 days
| 8 |
|
|
391.0 |
g |
6.0 |
16.97 |
body weighing method |
|
0.0 |
|
|
102787 |
2723 |
| LH/Mav |
urine sodium level to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133.0 days
| 10 |
|
|
0.49 |
mmol/l/100g |
0.04 |
0.13 |
flame photometry |
|
0.0 |
|
|
102053 |
2645 |
| LH/Mav |
diastolic blood pressure |
control condition |
Dubay C, et al., Nat Genet 1993 Apr;3(4):354-7 |
arterial blood pressure trait |
male |
203.0 days-217.0 days |
16 |
|
serial mean |
118.4 |
mmHg |
|
|
vascular indwelling catheter method |
abdominal aorta |
10800 |
|
|
11647 |
111 |
| LH/Mav |
urine total protein excretion rate |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
total urine protein amount |
male |
112.0 days
| 8 |
|
|
182.0 |
mg/d |
24.0 |
67.88 |
urine protein analysis |
|
0.0 |
|
|
102810 |
2723 |
| LH/Mav |
urine total protein excretion rate |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
total urine protein amount |
male |
161.0 days
| 8 |
|
|
260.0 |
mg/d |
27.0 |
76.37 |
urine protein analysis |
|
0.0 |
|
|
102812 |
2723 |
| LH/Mav |
systolic blood pressure |
control condition (between 147 and 154 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
147.0 days-154.0 days |
6 |
2hr mean (10a-12p) |
continuous mean |
175.0 |
mmHg |
1.0 |
2.45 |
vascular fluid filled catheter |
|
0.0 |
|
|
103436 |
2825 |
| LH/Mav |
body weight |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
body mass |
male |
161.0 days
| 8 |
|
|
442.0 |
g |
8.0 |
22.63 |
body weighing method |
|
0.0 |
|
|
102801 |
2723 |
| LH/Mav |
body weight |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
body mass |
male |
112.0 days
| 4 |
|
|
374.0 |
g |
6.0 |
12.0 |
body weighing method |
|
0.0 |
|
|
102791 |
2723 |
| LH/Mav |
urine sodium level to urine potassium level ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133.0 days
| 10 |
|
|
0.12 |
null |
0.01 |
0.03 |
flame photometry |
|
0.0 |
|
|
102065 |
2645 |